DAX®13.620,46-1,81%TecDAX®3.400,21+0,23%Dow Jones 3030.545,99-1,26%Nasdaq 10013.230,03-1,93%
finanztreff.de

DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. increases size of the convertible bond offering due to high demand.

| Quelle: Dow Jones Newsw... | Lesedauer etwa 8 min. | Text vorlesen Stop Pause Fortsetzen

DGAP-Ad-hoc: SHOP APOTHEKE EUROPE N.V. / Key word(s): Issue of Debt/Financing
SHOP APOTHEKE EUROPE N.V. increases size of the convertible bond offering due to high demand.
14-Jan-2021 / 14:53 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
^NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA,
JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE
LAWS.
SHOP APOTHEKE EUROPE N.V. increases size of the convertible bond offering due to high demand.
Venlo, January 14, 2021. - SHOP APOTHEKE EUROPE N.V. (the "Company") has decided to increase the size of the offering
of the senior unsecured convertible bonds due 2028 (the "Bonds") which was announced today due to high demand. The
issue size of the Bonds will now be increased to an aggregate principal amount of EUR 225 million.

Contact:
rikutis consulting
Thomas Schnorrenberg
Cel: +49 151 46 53 13 17
E-Mail: presse@shop-apotheke.com
Information and Explanation of the Issuer to this News:
ABOUT SHOP APOTHEKE EUROPE.
SHOP APOTHEKE EUROPE is one of the leading and fastest-growing online pharmacies in Continental Europe. With the
acquisition of Europa Apotheek Venlo in November 2017, SHOP APOTHEKE EUROPE significantly extended its European market
leadership. The product range for the whole family in the areas of OTC, beauty and personal care products as well as
prescription drugs is supplemented by high quality natural food and health products, low carb products and sports
nutrition following the acquisition of nu3 GmbH in July 2018.
SHOP APOTHEKE EUROPE operates online pharmacies in Germany, Austria, France, Belgium, Italy, the Netherlands and
Switzerland at this moment. SHOP APOTHEKE EUROPE delivers a broad range of more than 100,000 original products to 6.3
million active customers (31 December 2020) fast and at attractive prices. In addition, SHOP APOTHEKE EUROPE provides
comprehensive pharmaceutical consulting services.
SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard)
since 13 October 2016 and has moved up to the MDAX index on 21 September 2020.
PRESS CONTACTS.
Trade and popular media:
Sven Schirmer
Tel: +49 221 99 53 44 31
Email: presse@shop-apotheke.com
Financial media:
Bettina Fries
Tel: +49 211 75 80 779
Email: presse@shop-apotheke.com
Investor relations:
Carmen Herkenrath
Tel.: +31 77 850 6109
Email: carmen.herkenrath@shop-apotheke.com
Thomas Schnorrenberg
Mobile: +49 151 465 31317
Email: presse@shop-apotheke.com
Disclaimers
This announcement may not be published, distributed or transmitted, directly or indirectly, in the United States of
America (including its territories and possessions), Australia, Japan, South Africa or any other jurisdiction where
such announcement could be unlawful. The distribution of this announcement may be restricted by law in certain
jurisdictions and persons who are in possession of this document or other information referred to herein should inform
themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a
violation of the securities laws of any such jurisdiction.
This announcement does not constitute an offer of, or a solicitation of an offer to purchase, securities of the Company
or of any of its subsidiaries in the United States of America, Germany or any other jurisdiction. Neither this
announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, an offer in
any jurisdiction. The securities offered will not be and have not been registered under the U.S. Securities Act of
1933, as amended (the 'Securities Act') and may not be offered or sold in the United States absent registration or an
applicable exemption from the registration requirements under the Securities Act.
In the United Kingdom, this announcement is only directed at persons who (i) are investment professionals falling
within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the
'Order') or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies,
unincorporated associations, etc. (all such persons together being referred to as 'Relevant Persons')). This document
must not be acted on, or relied upon, by persons who are not Relevant Persons. Any investment or investment activity to
which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons.
In member states of the European Economic Area the placement of securities described in this announcement is directed
exclusively at persons who are 'qualified investors' within the meaning of Regulation (EU) 2017/1129 of the European
Parliament and of the Council of 14 June 2017 (Prospectus Regulation).
The Bonds are not intended to be offered, sold or otherwise made available to and should not be offered, sold or
otherwise made available to any retail investor in the EEA. For these purposes, a 'Retail Investor' means a person who
is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of MIFID II; (ii) a customer within
the meaning of Directive (EU) 2016/97 (as amended, the 'Insurance Distribution Directive'), where that customer would
not qualify as a professional client as defined in point (10) of article 4(1) of MIFID II. Consequently, no key
information document required by Regulation (EU) No 1286/2014 (the 'PRIIPs Regulation') for offering or selling the
Bonds or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or
selling the Bonds or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs
Regulation.
The Bonds are not intended, to be offered, sold or otherwise made available to and should not be offered, sold or
otherwise made available to any retail investor in the United Kingdom ('UK'). For the purposes of this provision the
expression 'retail investor' means a person who is one (or more) of the following: (i) a retail client, as defined in
point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union
(Withdrawal) Act 2018 ('EUWA'); or (ii) a customer within the meaning of the provisions of the Financial Services and
Markets Act 2000 (the 'FSMA') and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97,
where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation
(EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA; or (iii) not a qualified investor as defined
in Article 2 of the Prospectus Regulation as it forms part of domestic law by virtue of the EUWA. Consequently no key
information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA
(the 'UK PRIIPs Regulation') for offering or selling the Notes or otherwise making them available to retail investors
in the UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any
retail investor in the UK may be unlawful under the UK PRIIPs Regulation.
No action has been taken that would permit an offering or an acquisition of the securities or a distribution of this
announcement in any jurisdiction where such action would be unlawful. Persons into whose possession this announcement
comes are required to inform themselves about and to observe any such restrictions.
This announcement does not constitute a recommendation concerning the placement. Investors should consult a
professional advisor as to the suitability of the placement for the person concerned.
This release may contain forward looking statements, estimates, opinions and projections with respect to anticipated
future performance of the Company ('forward-looking statements'). These forward-looking statements can be identified by
the use of forward-looking terminology, including the terms 'believes,' 'estimates,' 'anticipates,' 'expects,'
'intends,' 'may,' 'will' or 'should' or, in each case, their negative, or other variations or comparable terminology.
These forward-looking statements include all matters that are not historical facts. Forward-looking statements are
based on the current views, expectations and assumptions of the management of the Company and involve significant known
and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from
those expressed or implied in such statements. Forward-looking statements should not be read as guarantees of future
performance or results and will not necessarily be accurate indications of whether or not such results will be
achieved. Any forward-looking statements included herein only speak as at the date of this release. We undertake no
obligation, and do not expect to publicly update, or publicly revise, any of the information, forward-looking
statements or the conclusions contained herein or to reflect new events or circumstances or to correct any inaccuracies
which may become apparent subsequent to the date hereof, whether as a result of new information, future events or
otherwise. We accept no liability whatsoever in respect of the achievement of such forward-looking statements and
assumptions.


(MORE TO FOLLOW) Dow Jones Newswires

January 14, 2021 08:54 ET ( 13:54 GMT)
Werbung

Das könnte Sie auch interessieren

News-Suche

Suchbegriff:

Aktuelle Videos

HSBC Trading TV

Werbung

Trading-Tipp

Börsen & Märkte

US-Marktüberblick

zur Mediathek
Werbung

Werbung
Diese Seite empfehlenschliessen
Interessant, oder?
Teilen Sie diese Seite auf Facebook oder Twitter
Wenn Sie auf die Teilen-Buttons klicken und sich bei den Betreibern einloggen, werden Daten an den jeweiligen Betreiber übermittelt. Bitte beachten Sie die Datenschutzerklärung.
Aktuelle Umfrageschliessen
Die Kurse der Lufthansa-Aktie konnte sich seit November 2020 etablieren und zeigen seither einen stabilen, wenngleich überaus volatilen Aufwärtstrend. Dennoch lief der Start ins neue Jahr nicht ganz rund und so verlor der Titel doch stetig an Wert. Ist der Höhenflug gar schon wieder vorbei?
Jetzt abstimmen!
Alle Umfragen ansehen